Cefalea (III)cefalea en racimos, secundarias, farmacológicas y respondedoras a indometacina

  1. Higes Pascual, Félix
  2. Cubilla Salinas, M. A.
  3. Yusta Izquierdo, Antonio
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2015

Issue Title: Enfermedades del sistema nervioso (I): Cefaleas

Series: 11

Issue: 70

Pages: 4167-4183

Type: Article

DOI: 10.1016/S0304-5412(15)70895-4 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

The diagnosis of cluster headache is a well-defined clinical. Symptomatic treatment is the highflow inhaled oxygen. The headache is associated with a variety of processes, this requires when the pattern does not conform to a primary headache conduct appropriate studies. Often the presence of headache associated with the use of drugs such as adverse effects thereof. Some headaches characteristically respond to indomethacin and one of them is diagnosed as paroxysmal hemicrania and hemicrania continua criterion. Headache special consideration in certain age ranges for modifying the clinical expression of some primary headaches also prevalence and etiology of migraine changes with age. In the treatment in elderly patients should take into account the fragility of this age group (pluripatilogía, polypharmacy). In women there is a relationship between the influence of sex hormones and the clinical expression of primary headaches such as migraine which determines treatment guidelines. Pregnancy causes hormonal changes that influence the clinical course of primary headaches and the possibility of teratogenicity limits. There are headaches with low prevalence but whose knowledge is essential.

Bibliographic References

  • Nesbitt AD, Goadsby PJ. Cluster headache. BMJ. 2012;344:e20407.
  • Bahra A, Arne M, Goadsby P. Cluster headache. A prospective clinical study with diagnostic implications. Neurology. 2002;58:354-61.
  • Sjaastad O, editor. Cluster headache syndrome. London: WB Saunders Company Ltd; 1992.
  • Manzoni GC, Terzano MG, Bono G, Micieli G, Martucci N, Nappi G. Cluster headache-clinical findings in 180 patients. Cephalalgia. 1983;3:21.
  • Drummond PD. Mechanism of autonomic disturbance in the face during and between attacks of cluster headache. Cephalalgia. 2006;26:633.
  • Nappi G, Micieli G, Cavallini A, Zanferrari C, Sandrini G, Man-zoni GC, et al. Accompanying symptoms of cluster headache attacks: their relevence to the diagnostic criteria. Cephalalgia. 1992;12:165:8.
  • Sjaastad O, Antonance F, Fragoso YD. Cluster headache further observa-tions on the dissociation of pain and autonomic findings. Cephalalgia. 1988;8:127-32.
  • Kurzewski P, Bordini C, Brubakk AO, Sjaastad O. Cluster headache alte-rations in heart rate, blood presure and ortostatic responses during an spontaneus attack. Cephalalgia. 1992;12:172-7.
  • Kunkel RS. Classification of cluster headache: clinical features of episodic cluster headache. Houston: Cluster Headache MTP Press; 1984. p. 16-21.
  • Ekbom K. A clinical comparison of cluster headache and migraine. Scan. 1970;46Suppl41:1-44.
  • Drummond PD. Sweating and vascular responses in the face: normal re-gulation and dysfunction in migraina, cluster headache and harlequin syundrome. Clin Auton Resp. 1994;4:273.
  • Kudrow L. Cluster headache. Blue books of practical neurology. Boston: Butterwoth Heienemann; 1997. p. 227-42.
  • Headache Classification Commitee of the International Heada-che Society (IHS). The international Classification of Headache Disorders, 3rd ed (beta version). Cephalalgia. 2013;33:629.
  • Kudrow L. Subcronic cluster headache. Headache. 1987;27:197-200.
  • Manzoni GC, Micelli G, Zanferrari C, Cavallini A. Cluster headache-course over ten years in 189 patientes. Cephalalgia. 1991;11:169-74.
  • Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of clus-ter headache: a randomized trial. JAMA. 2009;302:2451.
  • Rozen TD. High oxygen flow rates for cluster headache. Neurology. 2004; 63:593.
  • May A. Cluster headache: pathogenesis, diagnosis and management. Lancet. 2005;366:843.
  • Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochra-ne database Syst Rev. 2010;CD008042.
  • Ekbom K. The Sumatriptan Cluster Headache Study Group: treatment of acute cluster headache with sumatriptan. N Engl J Med. 1991;325:322-6.
  • Ekbom K, Monstad I, Prusinski A, Cole J, Pilgrim AJ, Noronha D. Sub-cutaneous sumatriptan in the acute tretment of cluster headache: A dose comparison study. Acta Neurol Scan. 1993;88:63-9.
  • Hardebo JE, Dahlof C. Sumatriptan nasal spray (20 mg/dose) in the acu-te tretment of cluster headache. Cephalalgia. 1998;18:487-9.
  • Bhara A, Gawel MJ, Hardebo JE. Oral zolmitriptan is efective in the acu-te treatment of cluster headache. Neurology. 2000;54:1832-9.
  • Pascual J, Navarro A, Caminero B, Jurado C. Experiencia con zolmitrip-tán nasal en la cefalea en racimos. Neurología. 2006;21(3):131-4.
  • Paemeliere K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medication overuse headache in patients with cluster headache. Neurology. 2006;67:109.
  • Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double blind crosso-ver study. Ann Neurol. 2004;56:488.
  • Robbins L. Intranasal lidocaine for cluster headache. Headache 1995;35: 83-4.
  • Nagy AJ, Gandhi S, Bhola R, Goadsby PJ. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology. 2011;77:1827.
  • May A, Leone M, Afra J, Linde M, Sándor PS, Evers S. EFNS guidelines on the treatment of cluster headache and other trigemi-nal autonomic cephalalgias. Eur J Neurol. 2006;13:1066.
  • Dodick DW, Capobianco DJ. Treatment and management of cluster hea-dache. Curr Pain Headache Rep. 2001;5:83.
  • Leone M, D ́Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology. 2000;54:1382.
  • Ekbom K, Hardebo JE. Cluster headache: aetiology, diagnosis and mana-gement. Drugs. 2002;62:61.
  • Leone M, Dodick D, Rigamonti A, D’Amico D, Grazzi L, Mea E, et al. Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia. 2003;23:1001.
  • Hering R, Kuritzky A. Sodium valproate in the treatment of cluster hea-dache: an open clinical trial. Cephalalgia. 1989;9:195-8.
  • El Amrani M, Massiou H, Bousser MG. A negative trial of sodium val-proate in cluster headache: methodological issues. Cephalalgia. 2002;22:205.
  • Speight TM, Avery GS. Pizotifen (BC-105): a review of its pharmacolo-gical properties and its therapeutic efficcy in vascular headaches. Drugs. 1972;3:159.
  • Prakash S, Shah ND, Chavda BV. Cluster headache responsive to indo-metacin: Case reports and a critical review of the literature. Cephalalgia. 2010;30:975.
  • Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Reatment of heada-che with botulinum toxin A-a review according to evidence-bases medi-cine criteria. Cephalalgia. 2002;22:699.
  • Schoenen J, Jensen RH, Lantéri-Minet M, Láinez MJ, Gaul C, Goodman AM, et, al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia. 2013;33:816.
  • Gantenbein AR, Lutz NJ, Riederer F, Sandor PS. Efficacy and safety of 121 injections of the greater occipital nerve in episodic and cronic cluster heada-che. Cephalalgia. 2012;32:630.
  • Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation in 14 patients. Neurology. 2009;72:341.
  • Leone M, Franzini A, Broggi G, Bussone G. Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology. 2006;67:150.
  • Schoenen J, Di Clemente L, Vandenheede M, Fumal A, De Pasqua V, Mou-champs M, et al. Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain. 2005;128:940.
  • Pareja JA, Caminero AB, Dobato JL. Cefalea punzante idiopática. Neurología. 1997;12 Supl5:56-60.
  • Pascual J, Iglesias F, Oterino A, Vázquez-Barbero A, Berciano J. Cough exer-tional and sexual headaches. An analysis of 72 benign and symptomatic cases. Neurology. 1996;46:1520-4.
  • Frese A, EikermanA, Frese K, Schwag S, Hunstedt IW, Evers W. Headaches associated with sexual activity: demography, clinical features and comorbidity. Neurology. 2003;23:796-800.
  • Evans RW, Pascual J. Orgasmic headaches: clinical features, diagnosis and ma-nagement. Headache. 2000;40:491-4.
  • Lewis D, Ashwal S, Hershey A, Hirtz D, Yonkes M, Silberstein S. et al. Practi-ce parameter: pharmacological treatment of migraine headaches in children and adolescents: report of the American Academy of Neurology Quality Stan-dards Subcommittee and de Practice Committee of de Child Neurology So-ciety. Neurology. 2004;63:2215.
  • McDonald JT. Treatment of juvenile migraine with subcuteneous sumatriptan. Headache. 1995;34:581.
  • Tai ML, Jivanadham JS, Tan CT, Sharma VK. Primary headache in the elderly in South-East Asia. J Headache Pain. 2012;13:291-7.
  • Mazoni GC, Stovner LJ. Epidemiology of headache. Hand Lin Neurol. 2011;97:1-22.
  • Lisotto C, Mainardi F, Maggione F, Dainese F, Zanchin G. Headache in the el-derly. A clinical study. J Headache Pain. 2004;5:36-41.
  • Ruiz M, Pedraza MI, de la Cruz C, Barón J, Muñoz I, Rodríguez C, et al. Cefaleas en la persona mayor: características de una serie de 262 pacientes. Neurología. 2014;26:321-6.
  • Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and bur-den of migrain in the United States: data from the American Migraine Stady II. Headache. 2001;41:646-57.
  • Raña-Martínez N. Migraña en la mujer. Rev Neurol. 2008;46:373-8.
  • Chavanu KJ, O ́Donell DC. Hormonal interventions for menstrual migraine. Pharmacotherapy. 2002;22:1442-57.
  • Morales F, Mostacero E, Sánchez MJ. Vascular malformation of the cerebellopon-tine angle associated with SUNCT syndrome. Cephalalgia. 1994;14:301-2.
Data source: Dialnet